《沪深股市》上证深成半日跌0.2%至0.8% 内险股逆市造好 白酒股续跌
外围股市连日造好,美股道指上破30,000关。人行今日进行1,200亿人民币(下同)逆回购操作,单日净投放200亿元。人汇回升,上证深成今早高开後回软。
上证半日跌7点或0.2%,收报3,395点;深成跌106点或0.8%,收报13,795点;沪深300跌13点或0.3%,收报4,960。沪深两市成交额分别为2,371亿元及3,008亿元。创业板指数跌32点或1.2%,收报2,642点,成交额1,166亿元。
金融股表现向好,工行(601398.SH)、建行(601939.SH)分别升0.6%及0.8%。内险股逆市显着上扬,国寿(601628.SH)、中国平安(601318.SH)、太保(601601.SH)、新华保险(601336.SH)升2.4%至6.7%。
国际油价上扬,刺激石油相关股造好,中曼石油(603619.SZ)、洲际油气(600759.SH)分别扬7.1%及5.9%。中国石油(601857.SH)、中国石化(600028.SH)分别升1.2%及2.4%。
煤炭股走个别,大同煤业(601001.SH),云煤能源(600792.SH)分别吐2.6%及2.3%。金能科技(603113.SH)、郑州煤电(600121.SH)分别扬8.5%及9.7%。
白酒股显着回吐,青青稞酒(002646.SZ)挫8.9%。金徽酒(603919.SH)、老白干酒(600559.SH)、金种子酒(600199.SH)跌4.6%至7.1%。
汽车股继续炒上,长安汽车(000625.SZ)、小康股份(601127.SH)涨停。江淮汽车(600418.SH)升4.3%。
部分半导体股表现向好,台基股份(300046.SZ)、斯达半导(603290.SH)各升逾3%。
国药股份(600511.SH)扬7%,国药一致(000028.SZ)升3.7%。中国国药集团已向国家药监局提交了新冠疫苗上市申请。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.